Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | WDR5 | P61964 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26725099 | 1.00 | ALDH1A1 (0.50) | ALDH1A1MMP3BCL2L1CA1CA2 | |
| SCHEMBL19773091 | 0.87 | ALDH1A1 (0.40) | ALDH1A1MMP3BCL2L1CA1CA2 | |
| SCHEMBL21587175 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MMP3BCL2L1CA1CA2 | |
| SCHEMBL27354695 | 0.84 | BACE1 (0.39) | ALDH1A1MMP3BCL2L1HSD17B10ALOX5 | |
| SCHEMBL21975473 | 0.84 | L3MBTL1 (0.50) | ALDH1A1MAPK1MAPTSMN1; SMN2LMNA | |
| SCHEMBL470219 | 0.82 | — | — | |
| SCHEMBL20083349 | 0.82 | HSD17B1 (0.52) | ALDH1A1MAPK1CYP1A2CYP3A4KDM4E | |
| SCHEMBL15457924 | 0.80 | ESR1 (0.57) | CYP1A2CYP3A4ALOX5ESR1ESR2 | |
| Water SCHEMBL27726941 | 0.79 | TDP1 (0.37) | ALDH1A1CA1CA2HSD17B10CYP3A4 | |
| SCHEMBL14644816 | 0.79 | ALDH1A1 (0.45) | ALDH1A1MMP3BCL2L1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140947-A1 | METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES | Basell Polyolefine GmbH (DE) | 2001-10-10 | — | — | EP | claimed |
| WO-2000037476-A1 | METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES | BASELL POLYOLEFINE GMBH (DE) | 2000-06-29 | — | — | WO | claimed |
| WO-2024013276-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2024-01-18 | — | — | WO | disclosed |
| EP-3767694-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2023-09-13 | — | — | EP | disclosed |
| US-20230124929-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-04-20 | — | — | US | disclosed |
| WO-2022250244-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2022-12-01 | — | — | WO | disclosed |
| EP-3390365-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-04-14 | — | — | EP | disclosed |
| EP-3767694-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-20 | — | — | EP | disclosed |
| US-10361380-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-23 | — | — | US | disclosed |
| EP-3261146-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2017-12-27 | — | — | EP | disclosed |
| EP-2399584-A1 | Boronic acids and esters as inhibitors of fatty acid amide hydrolase | Infinity Pharmaceuticals, Inc. (US) | 2011-12-28 | — | — | EP | disclosed |
| WO-2011006568-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-01-20 | — | — | WO | disclosed |
| WO-2007092208-A1 | PHOTOTHERMOGRAPHIC MATERIALS INCORPORATING ARYLBORONIC ACIDS | CARESTREAM HEALTH, INC. (US) | 2007-08-16 | — | — | WO | disclosed |
| EP-1140947-A1 | METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES | Basell Polyolefine GmbH (DE) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037476-A1 | METHOD FOR PRODUCING MONO-ORGANOBORANES OR DI-ORGANOBORANES | BASELL POLYOLEFINE GMBH (DE) | 2000-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230124929-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | EXOC1, RPS10, EXOSC10 | ALDH1A1 1811/4885MMP3 4386/4885BCL2L1 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.